Precipio, Inc. (PRPO)
USD 5.45
(4.01%)
USD 5.45
(4.01%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 18.1 Million USD | -15.82% |
| 2022 | 21.5 Million USD | -29.35% |
| 2021 | 30.43 Million USD | 46.96% |
| 2020 | 20.71 Million USD | 6.16% |
| 2019 | 19.51 Million USD | -9.69% |
| 2018 | 21.6 Million USD | -20.74% |
| 2017 | 27.26 Million USD | 2065.21% |
| 2016 | 1.25 Million USD | -73.86% |
| 2015 | 4.81 Million USD | -83.95% |
| 2014 | 30 Million USD | -0.9% |
| 2013 | 30.27 Million USD | -21.95% |
| 2012 | 38.79 Million USD | 15.58% |
| 2011 | 33.56 Million USD | 4.79% |
| 2010 | 32.02 Million USD | 100.12% |
| 2009 | 16 Million USD | -8.84% |
| 2008 | 17.55 Million USD | -8.04% |
| 2007 | 19.09 Million USD | -10.66% |
| 2006 | 21.36 Million USD | -15.68% |
| 2005 | 25.34 Million USD | -32.35% |
| 2004 | 37.45 Million USD | -34.64% |
| 2003 | 57.3 Million USD | -22.6% |
| 2002 | 74.03 Million USD | -17.08% |
| 2001 | 89.28 Million USD | 14.67% |
| 2000 | 77.86 Million USD | 290.03% |
| 1999 | 19.96 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 16.62 Million USD | -8.16% |
| 2024 Q2 | 17.31 Million USD | 4.17% |
| 2023 Q3 | 19.05 Million USD | -2.15% |
| 2023 FY | 18.1 Million USD | -15.82% |
| 2023 Q1 | 19.42 Million USD | -9.68% |
| 2023 Q2 | 19.47 Million USD | 0.25% |
| 2023 Q4 | 18.1 Million USD | -5.0% |
| 2022 Q1 | 27.97 Million USD | -8.11% |
| 2022 Q2 | 25.97 Million USD | -7.12% |
| 2022 Q3 | 23.54 Million USD | -9.36% |
| 2022 FY | 21.5 Million USD | -29.35% |
| 2022 Q4 | 21.5 Million USD | -8.68% |
| 2021 FY | 30.43 Million USD | 46.96% |
| 2021 Q1 | 20.42 Million USD | -1.4% |
| 2021 Q2 | 33.54 Million USD | 64.23% |
| 2021 Q3 | 31.6 Million USD | -5.77% |
| 2021 Q4 | 30.43 Million USD | -3.69% |
| 2020 Q4 | 20.71 Million USD | -0.02% |
| 2020 Q3 | 20.71 Million USD | 8.84% |
| 2020 Q2 | 19.03 Million USD | 0.21% |
| 2020 Q1 | 18.99 Million USD | -2.64% |
| 2020 FY | 20.71 Million USD | 6.16% |
| 2019 Q4 | 19.51 Million USD | -13.38% |
| 2019 Q3 | 22.52 Million USD | 1.44% |
| 2019 FY | 19.51 Million USD | -9.69% |
| 2019 Q1 | 21.63 Million USD | 0.16% |
| 2019 Q2 | 22.2 Million USD | 2.62% |
| 2018 Q3 | 24.65 Million USD | -4.79% |
| 2018 FY | 21.6 Million USD | -20.74% |
| 2018 Q4 | 21.6 Million USD | -12.35% |
| 2018 Q2 | 25.88 Million USD | -0.78% |
| 2018 Q1 | 26.09 Million USD | -4.28% |
| 2017 FY | 27.26 Million USD | 2065.21% |
| 2017 Q4 | 27.26 Million USD | -22.06% |
| 2017 Q3 | 34.97 Million USD | -5.49% |
| 2017 Q2 | 37.01 Million USD | 2911.39% |
| 2017 Q1 | 1.22 Million USD | -2.38% |
| 2016 Q4 | 1.25 Million USD | -39.41% |
| 2016 FY | 1.25 Million USD | -73.86% |
| 2016 Q3 | 2.07 Million USD | -32.84% |
| 2016 Q1 | 3.59 Million USD | -25.42% |
| 2016 Q2 | 3.09 Million USD | -13.86% |
| 2015 Q3 | 24.45 Million USD | -22.16% |
| 2015 FY | 4.81 Million USD | -83.95% |
| 2015 Q4 | 4.81 Million USD | -80.3% |
| 2015 Q2 | 31.4 Million USD | -8.94% |
| 2015 Q1 | 34.49 Million USD | 14.95% |
| 2014 Q4 | 30 Million USD | -2.73% |
| 2014 FY | 30 Million USD | -0.9% |
| 2014 Q3 | 30.84 Million USD | -0.78% |
| 2014 Q2 | 31.09 Million USD | 1.22% |
| 2014 Q1 | 30.71 Million USD | 1.45% |
| 2013 Q3 | 33.18 Million USD | -15.71% |
| 2013 Q1 | 41.39 Million USD | 6.72% |
| 2013 FY | 30.27 Million USD | -21.95% |
| 2013 Q4 | 30.27 Million USD | -8.75% |
| 2013 Q2 | 39.36 Million USD | -4.92% |
| 2012 Q3 | 42.88 Million USD | -4.0% |
| 2012 Q1 | 47.18 Million USD | 40.59% |
| 2012 FY | 38.79 Million USD | 15.58% |
| 2012 Q4 | 38.79 Million USD | -9.55% |
| 2012 Q2 | 44.67 Million USD | -5.32% |
| 2011 FY | 33.56 Million USD | 4.79% |
| 2011 Q4 | 33.56 Million USD | 11.97% |
| 2011 Q3 | 29.97 Million USD | -2.36% |
| 2011 Q2 | 30.7 Million USD | -2.22% |
| 2011 Q1 | 31.39 Million USD | -1.96% |
| 2010 Q3 | 13.93 Million USD | -3.52% |
| 2010 Q4 | 32.02 Million USD | 129.8% |
| 2010 FY | 32.02 Million USD | 100.12% |
| 2010 Q1 | 16.21 Million USD | 1.33% |
| 2010 Q2 | 14.44 Million USD | -10.92% |
| 2009 FY | 16 Million USD | -8.84% |
| 2009 Q1 | 16.8 Million USD | -4.27% |
| 2009 Q2 | 16.08 Million USD | -4.29% |
| 2009 Q3 | 15.35 Million USD | -4.54% |
| 2009 Q4 | 16 Million USD | 4.23% |
| 2008 Q1 | 19.78 Million USD | 3.66% |
| 2008 FY | 17.55 Million USD | -8.04% |
| 2008 Q3 | 17.95 Million USD | -6.18% |
| 2008 Q4 | 17.55 Million USD | -2.19% |
| 2008 Q2 | 19.13 Million USD | -3.31% |
| 2007 Q1 | 20.18 Million USD | -5.52% |
| 2007 FY | 19.09 Million USD | -10.66% |
| 2007 Q2 | 20.77 Million USD | 2.91% |
| 2007 Q4 | 19.09 Million USD | -6.95% |
| 2007 Q3 | 20.51 Million USD | -1.26% |
| 2006 Q1 | 24.91 Million USD | -1.7% |
| 2006 Q4 | 21.36 Million USD | -1.59% |
| 2006 Q3 | 21.71 Million USD | -9.17% |
| 2006 Q2 | 23.9 Million USD | -4.03% |
| 2006 FY | 21.36 Million USD | -15.68% |
| 2005 Q2 | 32.96 Million USD | -3.99% |
| 2005 Q3 | 31.78 Million USD | -3.57% |
| 2005 Q4 | 25.34 Million USD | -20.29% |
| 2005 Q1 | 34.33 Million USD | -8.33% |
| 2005 FY | 25.34 Million USD | -32.35% |
| 2004 Q2 | 46.3 Million USD | -21.32% |
| 2004 Q4 | 37.45 Million USD | -10.12% |
| 2004 FY | 37.45 Million USD | -34.64% |
| 2004 Q1 | 58.85 Million USD | 2.7% |
| 2004 Q3 | 41.67 Million USD | -10.0% |
| 2003 Q4 | 57.3 Million USD | -7.39% |
| 2003 Q3 | 61.88 Million USD | -5.85% |
| 2003 FY | 57.3 Million USD | -22.6% |
| 2003 Q1 | 71.09 Million USD | -3.97% |
| 2003 Q2 | 65.72 Million USD | -7.55% |
| 2002 Q2 | 83.52 Million USD | -4.59% |
| 2002 Q3 | 80.37 Million USD | -3.77% |
| 2002 FY | 74.03 Million USD | -17.08% |
| 2002 Q1 | 87.54 Million USD | -1.95% |
| 2002 Q4 | 74.03 Million USD | -7.89% |
| 2001 Q1 | 77.34 Million USD | -0.67% |
| 2001 Q2 | 92.11 Million USD | 19.11% |
| 2001 FY | 89.28 Million USD | 14.67% |
| 2001 Q3 | 89.41 Million USD | -2.93% |
| 2001 Q4 | 89.28 Million USD | -0.15% |
| 2000 Q4 | 77.86 Million USD | -6.71% |
| 2000 Q1 | 18.82 Million USD | 0.0% |
| 2000 Q3 | 83.46 Million USD | 422.51% |
| 2000 FY | 77.86 Million USD | 290.03% |
| 2000 Q2 | 15.97 Million USD | -15.17% |
| 1999 FY | 19.96 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Biodesix, Inc. | 99.09 Million USD | 81.734% |
| Castle Biosciences, Inc. | 477.81 Million USD | 96.212% |
| Exact Sciences Corporation | 6.47 Billion USD | 99.72% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 99.445% |
| 23andMe Holding Co. | 395.16 Million USD | 95.419% |
| NeoGenomics, Inc. | 1.68 Billion USD | 98.923% |
| Neogen Corporation | 4.58 Billion USD | 99.605% |
| Inotiv, Inc. | 856.53 Million USD | 97.887% |
| Psychemedics Corporation | 13.27 Million USD | -36.405% |
| RadNet, Inc. | 2.88 Billion USD | 99.373% |
| Star Equity Holdings, Inc. | 86.97 Million USD | 79.188% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -120.165% |
| Illumina, Inc. | 10.11 Billion USD | 99.821% |
| Aspira Women's Health Inc. | 6.26 Million USD | -189.061% |
| Prenetics Global Limited | 254.17 Million USD | 92.878% |
| iSpecimen Inc. | 15.81 Million USD | -14.425% |
| OpGen, Inc. | 1.88 Million USD | -861.656% |
| T2 Biosystems, Inc. | 34.79 Million USD | 47.981% |
| Standard BioTools Inc. | 323.06 Million USD | 94.397% |
| Neuronetics, Inc. | 115.83 Million USD | 84.373% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -31.368% |
| Exagen Inc. | 56.94 Million USD | 68.213% |
| Bionano Genomics, Inc. | 214.4 Million USD | 91.558% |
| CareDx, Inc | 484.61 Million USD | 96.265% |
| Check-Cap Ltd. | 25.01 Million USD | 27.645% |
| Twist Bioscience Corporation | 776.4 Million USD | 97.669% |
| Guardant Health, Inc. | 1.78 Billion USD | 98.987% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -58.784% |
| Natera, Inc. | 1.45 Billion USD | 98.758% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | 98.578% |
| Sera Prognostics, Inc. | 95.44 Million USD | 81.034% |
| OPKO Health, Inc. | 2.01 Billion USD | 99.1% |
| Personalis, Inc. | 225.09 Million USD | 91.959% |
| Aclaris Therapeutics, Inc. | 197.4 Million USD | 90.831% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -32.593% |
| Myriad Genetics, Inc. | 1.19 Billion USD | 98.49% |
| ICON Public Limited Company | 16.98 Billion USD | 99.893% |
| Star Equity Holdings, Inc. | 86.97 Million USD | 79.188% |
| MDxHealth SA | 129.13 Million USD | 85.983% |
| Prenetics Global Limited | 254.17 Million USD | 92.878% |
| DarioHealth Corp. | 96.38 Million USD | 81.221% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -167.998% |
| Medpace Holdings, Inc. | 1.65 Billion USD | 98.907% |
| Mainz Biomed B.V. | 15.4 Million USD | -17.47% |
| Trinity Biotech plc | 59.43 Million USD | 69.545% |
| Sotera Health Company | 3.13 Billion USD | 99.422% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -120.165% |